Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma.
Barone A, Hazarika M, Theoret MR, Mishra-Kalyani P, Chen H, He K, Sridhara R, Subramaniam S, Pfuma E, Wang Y, Li H, Zhao H, Zirkelbach JF, Keegan P, Pazdur R. Barone A, et al. Among authors: sridhara r. Clin Cancer Res. 2017 Oct 1;23(19):5661-5665. doi: 10.1158/1078-0432.CCR-16-0664. Epub 2017 Feb 8. Clin Cancer Res. 2017. PMID: 28179454 Clinical Trial.
FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets.
Cohen MH, Williams GA, Sridhara R, Chen G, Pazdur R. Cohen MH, et al. Among authors: sridhara r. Oncologist. 2003;8(4):303-6. doi: 10.1634/theoncologist.8-4-303. Oncologist. 2003. PMID: 12897327 Free article. Clinical Trial.
Pemetrexed in malignant pleural mesothelioma.
Hazarika M, White RM Jr, Booth BP, Wang YC, Ham DY, Liang CY, Rahman A, Gobburu JV, Li N, Sridhara R, Morse DE, Lostritto R, Garvey P, Johnson JR, Pazdur R. Hazarika M, et al. Among authors: sridhara r. Clin Cancer Res. 2005 Feb 1;11(3):982-92. Clin Cancer Res. 2005. PMID: 15709163
FDA drug approval summary: erlotinib (Tarceva) tablets.
Cohen MH, Johnson JR, Chen YF, Sridhara R, Pazdur R. Cohen MH, et al. Among authors: sridhara r. Oncologist. 2005 Aug;10(7):461-6. doi: 10.1634/theoncologist.10-7-461. Oncologist. 2005. PMID: 16079312 Free article. Clinical Trial.
Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.
Johnson JR, Cohen M, Sridhara R, Chen YF, Williams GM, Duan J, Gobburu J, Booth B, Benson K, Leighton J, Hsieh LS, Chidambaram N, Zimmerman P, Pazdur R. Johnson JR, et al. Among authors: sridhara r. Clin Cancer Res. 2005 Sep 15;11(18):6414-21. doi: 10.1158/1078-0432.CCR-05-0790. Clin Cancer Res. 2005. PMID: 16166415 Clinical Trial.
167 results